Palatin Technologies Inc. Common Stock (PTN)
Stock · NASDAQ · Health Care
$6.01as of 10/16/2026
Price chart
Active signals
PTN Signal Track Record
How signals performed across all stocks →What PTN's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakdown | 20 | -7.8% | 40% | July 14, 2026 |
| Bollinger Band Breakout | 18 | -5.3% | 39% | September 2, 2026 |
| Volume SpikeActive now | 13 | -8.7% | 38% | August 31, 2026 |
| 200-Day Moving Average TouchActive now | 3 | -20.4% | 0% | May 14, 2026 |
| Any 20-session window (baseline) | -7.0% | 37% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About PTN
Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity completed Phase 2 clinical trial; completed…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 25
- Website
- www.palatin.com/
Fundamentals
- 1-day range
- $6.08$6.93
- Market cap
- $14.00M
- P/E (trailing)
- 92.55
- P/E (forward)
- -3.29
- EPS (trailing)
- $-0.08
- Dividend yield
- —
- Beta
- 0.85
- Avg. volume
- 63.7K
How Palatin Technologies Inc. Common Stock Makes Money
Where the revenue actually goes — FY2026 annual results
Source: 10-K filed Sep 28, 2026 · via SEC EDGAR / Finnhub
Forecasts
3 analyst ratings
Palatin Technologies Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- PTNPalatin Technologies Inc. Common Stock$6.02▼ 7.24%Market cap $14.00MP/E 92.55$5.61$31
- AKTXAkari Therapeutics plc ADS$8.18▼ 7.47%Market cap $14.14MP/E Infinity$3.02$39.64
- COCPCocrystal Pharma Inc. Common Stock$1.02▼ 0.97%Market cap $14.20MP/E —$0.76$2.03
- AEONAEON Biopharma Inc. Class A Common Stock$0.232▼ 4.53%Market cap $13.80MP/E —$0.1772$1.45
- KALAKALA BIO Inc. Common Stock$0.19▼ 1.04%Market cap $14.25MP/E —$0.2593$95.5
- TPSTTempest Therapeutics Inc. Common Stock$0.624▼ 1.73%Market cap $14.42MP/E —$0.6801$12.23
- GTBPGT Biopharma Inc. Common Stock$7.03▼ 4.48%Market cap $13.35MP/E —$4.91$34.25
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| PTN Palatin Technologies Inc. Common Stock | $14.00M | 92.55 | $6.02 | ▼ 7.24% | $5.61$31 |
| AKTX Akari Therapeutics plc ADS | $14.14M | Infinity | $8.18 | ▼ 7.47% | $3.02$39.64 |
| COCP Cocrystal Pharma Inc. Common Stock | $14.20M | — | $1.02 | ▼ 0.97% | $0.76$2.03 |
| AEON AEON Biopharma Inc. Class A Common Stock | $13.80M | — | $0.232 | ▼ 4.53% | $0.1772$1.45 |
| KALA KALA BIO Inc. Common Stock | $14.25M | — | $0.19 | ▼ 1.04% | $0.2593$95.5 |
| TPST Tempest Therapeutics Inc. Common Stock | $14.42M | — | $0.624 | ▼ 1.73% | $0.6801$12.23 |
| GTBP GT Biopharma Inc. Common Stock | $13.35M | — | $7.03 | ▼ 4.48% | $4.91$34.25 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Palatin Technologies, Inc. Q4 2026 Earnings Call SummaryYahoo · 9/29/2026
- Palatin Technologies, Inc. (PTN) Q4 2026 Earnings Call TranscriptSeekingAlpha · 9/28/2026
- Palatin Reports Fiscal Year 2026 Financial Results and Provides Business UpdateYahoo · 9/28/2026
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga · 9/28/2026
- Gold Fields, Harmony Gold Mining, Anglogold Ashanti And Other Big Stocks Moving Lower In Monday’s Pre-Market SessionBenzinga · 9/28/2026
- Palatin Techs Q4 EPS $(1.11) Up From $(2.73) YoY, Sales $300.770KBenzinga · 9/28/2026
- Why Webuy Global Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving PremarketBenzinga · 9/28/2026
Insider Activity
Insider Actions →- Arlene Morris · August 3, 2026 · Z2.4K
- Alan W. Dunton · August 3, 2026 · Z2.2K
- John K. A. Prendergast · August 3, 2026 · Z2.9K
- Stephen T. Wills · July 15, 2026 · Tax Withholding94 @ $14.34
- Stephen T. Wills · July 15, 2026 · Tax Withholding79 @ $11.72
- Stephen T. Wills · July 15, 2026 · Tax Withholding22 @ $11.77
- Carl Spana · July 15, 2026 · Tax Withholding142 @ $14.34
- Carl Spana · July 15, 2026 · Tax Withholding119 @ $11.72
- Carl Spana · July 15, 2026 · Tax Withholding33 @ $11.77
Institutional Ownership
March 31, 2026
- Total shares held
- 761.1K
- Total value held
- $13.26M
- Institutional holders
- 24
- Unknown166.7K
- Unknown140.0K
- Unknown140.0K
- Unknown70.0K
- Unknown61.9K
- Unknown41.2K
- Unknown36.0K
- Unknown27.3K
- Unknown19.0K
- Unknown18.5K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
Palatin Reports Q4 2026 Results With Lower Losses
Palatin Technologies released its fiscal year 2026 financial results, reporting a Q4 loss of $1.11 per share, an improvement from the $2.73 loss in the same period last year. The company also reported sales of $300,770 for the quarter. This update provides the latest financial snapshot for the stock, which is currently trading near its 52-week low.
Palatin Reports Q4 2026 Results With Lower Losses. Palatin Technologies released its fiscal year 2026 financial results, reporting a Q4 loss of $1.11 per share, an improvement from the $2.73 loss in the same period last year. The company also reported sales of $300,770 for the quarter. This update provides the latest financial snapshot for the stock, which is currently trading near its 52-week low.